Serum fibrinogen is an independent prognostic factor in operable nonsmall cell lung cancer
Open Access
- 28 May 2013
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 133 (11) , 2720-2725
Abstract
Serum fibrinogen converted to insoluble fibrin by activated thrombin, plays an important role in the coagulation system. Increased fibrinogen considerably influences cancer cell growth, progression and metastasis. In nonsmall cell lung cancer (NSCLC), however, the association between serum fibrinogen concentration and prognosis has not been fully examined. We enlisted 567 operable NSCLC patients in our study. Preoperative serum fibrinogen was measured by the Clauss method. The association of serum fibrinogen concentration with clinical pathological factors and patient outcome was evaluated. Survival analysis indicated that serum fibrinogen was an independent prognostic factor in operable NSCLC. Patients with hyperfibrinogenemia had an elevated risk of disease progression and death compared to patients with normal fibrinogen levels. The hazard ratio was 1.49 (95% confidence interval [CI] 1.07–2.05) for disease progression and 1.64 (95% CI 1.06–2.53) for death. The trend linking increasing fibrinogen levels with risk was also statistically significant for both outcomes (p < 0.05). These analyses were adjusted for patient age, sex, smoking behavior, disease stage, tumor grade and histology. Kaplan–Meier survival curves showed similar results. Preoperative serum fibrinogen is a novel independent prognostic biomarker in operable NSCLC.Keywords
This publication has 33 references indexed in Scilit:
- Tumor response and survival in patients with advanced non-small-cell lung cancer: the predictive value of chemotherapy-induced changes in fibrinogenBMC Cancer, 2012
- Molecular biomarkers in non-small-cell lung cancer: a retrospective analysis of data from the phase 3 FLEX studyThe Lancet Oncology, 2011
- Decreased expression of thrombomodulin is correlated with tumor cell invasiveness and poor prognosis in nonsmall cell lung cancerMolecular Carcinogenesis, 2010
- Plasma Fibrinogen Levels and Prognosis in Patients with Ovarian Cancer: A Multicenter StudyThe Oncologist, 2009
- Platelets and fibrinogen facilitate each other in protecting tumor cells from natural killer cytotoxicityCancer Science, 2009
- Elevated Levels of Plasma Fibrinogen in Patients With Pancreatic CancerPancreas, 2009
- Pretreatment plasma fibrinogen level correlates with tumor progression and metastasis in patients with squamous cell carcinoma of the esophagusJournal of Gastroenterology and Hepatology, 2007
- Plasma fibrinogen and serum C-reactive protein are associated with non-small cell lung cancerLung Cancer, 2006
- Preoperative Serum Fibrinogen Level Predicts Postoperative Pulmonary Complications After Lung Cancer ResectionThe Annals of Thoracic Surgery, 2006
- The risk of a venous thrombotic event in lung cancer patients: higher risk for adenocarcinoma than squamous cell carcinomaJournal of Thrombosis and Haemostasis, 2004